Medical Imaging Markets

Product Code TRI00017
Publication Date May 2011
Publisher TriMark Publications
Product Type Report
Pages 239
ISBN Number not applicable
Change currency
PDF £2,150.00 €2,589 $3,400 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Medical Imaging Markets

The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about 108 million X-ray exams per year. MRI is second with 26 million examinations per year. PET, SPECT, CT and nuclear medicine rank third with 30 million examinations per year. Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As a result of these medical imaging advancements, the multi-slice systems are generating large volumes of data, and this creates demand for data storage, 3-D visualization and analysis. As such, the global medical imaging industry is primed to experience significant growth through the next decade. This report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included.

Contents

  • 1. Overview
    • 1.1 Statement of Report
    • 1.2 Scope of this Report
    • 1.3 Methodology
    • 1.4 Executive Summary
      • 1.4.1 Outlook for Medical Imaging
      • 1.4.2 Outlook for Computed Tomography (CT)
      • 1.4.3 Outlook for Magnetic Resonance Imaging (MRI)
      • 1.4.4 Outlook for Positron Emission Tomography (PET)
      • 1.4.5 Outlook for Single-Photon Emission Computed Tomography (SPECT)
      • 1.4.6 Outlook for Hybrid Modalities
      • 1.4.8 Outlook for Mammography
      • 1.4.9 Outlook for Digital Radiography/Computed Radiography (DR/CR)
      • 1.4.10 Outlook for Image-Guided Radiation Therapy (IGRT)
      • 1.4.11 Outlook for Cardiac CT Imaging
      • 1.4.12 Outlook for CT Angiography
      • 1.4.13 Outlook for Nuclear Medicine in Cardiac Imaging
      • 1.4.14 Outlook for MRI vs. SPECT in Cardiac Procedures
      • 1.4.15 Outlook for Echocardiography in Cardiac Imaging
      • 1.4.16 Outlook for Optical Coherence Tomography (OCT)
      • 1.4.17 Outlook for Health IT
    • 1.5 Market Drivers in Medical Imaging
      • 1.5.1 Diagnostic Imaging Hardware
      • 1.5.2 Miniaturization/Computing power
      • 1.5.3 Fusion/Multimodality
      • 1.5.4 Diagnostic Imaging Software
      • 1.5.5 3D/4D Imaging
      • 1.5.6 Computer-Aided Detection (CAD)
      • 1.5.7 Workflow Automation
      • 1.5.8 Enabling Technologies
      • 1.5.9 Digitization
      • 1.5.10 Client-Server Technology
      • 1.5.11 Interoperability and Standardization
    • 1.6 Challenges in Medical Imaging
      • 1.6.1 Legal and Regulatory Constraints
        • 1.6.1.1 U.S. Healthcare Reform
        • 1.6.1.2 Reimbursement
        • 1.6.1.3 Intellectual Property Protection for Imaging Software
        • 1.6.1.4 OEM Relationships
        • 1.6.1.5 Budgetary Concerns
        • 1.6.1.6 Equity Funding Constraints
      • 1.7.3 Breakeven Analysis for Magnetic Resonance Imaging (MRI)
      • 1.7.4 Reimbursement and Patient's Access for Medical Imaging in the U.S.
  • 2. Medical Imaging Technologies: A Brief Overview
    • 2.1 General X-rays in Medical Imaging
      • 2.1.1 Applications
    • 2.2 Computed Tomography (CT) in Medical Imaging
      • 2.2.1 Milestones in X-Ray CT
      • 2.2.2 Evolution of Multislice Spiral CT Scanning
      • 2.2.3 Computed Tomography (CT) Applications
      • 2.2.4 Main Drivers in X-ray CT
      • 2.2.5 Detector Channels per CT
      • 2.2.6 Advances in X-Ray CT
      • 2.2.7 Scanning Procedure
      • 2.2.8 Common Uses of CT Scanners
      • 2.2.9 Benefits of CT Scanning
      • 2.2.10 Risks Involved in CT Scanning
    • 2.3 Magnetic Resonance Imaging (MRI)
      • 2.3.1 Safety Measures
      • 2.3.2 Magnets in MRI Scanners
      • 2.3.3 Technology of MRI Scanner
      • 2.3.4 Visualization in MRI Scanner
      • 2.3.5 Advantages of MRI
      • 2.3.6 Disadvantages of MRI
    • 2.4 Positron Emission Tomography (PET)
      • 2.4.1 Common Uses of PET
      • 2.4.2 PET Procedure
      • 2.4.3 Benefits and Risks of PET Scans
      • 2.4.4 Limitations of PET
      • 2.4.5 Current Trends in PET and Hybrid Systems Design
      • 2.4.6 Trends in PET Instrumentation
      • 2.4.7 PET/CT
        • 2.4.7.1 Advances in PET/CT Hybrid Modality
        • 2.4.7.2 PET/CT Cancer Imaging
        • 2.4.7.3 PET Neuroimaging
        • 2.4.7.4 PET Cardiac Imaging
    • 2.5 Single Photon Emission Computed Tomography (SPECT)
      • 2.5.1 SPECT vs. PET
      • 2.5.2 SPECT/CT Cancer Imaging
      • 2.5.3 SPECT Neuroimaging
      • 2.5.4 SPECT Cardiac Imaging
    • 2.6 Ultrasound (US)
      • 2.6.1 Ultrasound Machine
      • 2.6.2 Different Types of Ultrasound
      • 2.6.3 3D Ultrasound
      • 2.6.4 Doppler Ultrasound
      • 2.6.5 Uses of Ultrasound in Obstetrics and Gynecology
      • 2.6.6 Uses of Ultrasound in Cardiology
      • 2.6.7 Uses of Ultrasound in Urology
      • 2.6.8 Ultrasound: Women's Preferred Imaging Modality
    • 2.7 Mammography
      • 2.7.1 Uses of Mammography
      • 2.7.2 Mammography Equipment and Procedure
      • 2.7.3 Benefits vs. Risks of Mammography
    • 2.8 Fluoroscopy
    • 2.9 Digital Radiography (DR)
    • 2.10 Computed Radiography (CR)
    • 2.11 Image-Guided Radiation Therapy
    • 2.12 Cardiac CT Imaging
    • 2.13 CT Angiography
    • 2.14 Nuclear Medicine in Cardiac Imaging
    • 2.15 Echocardiography in Cardiac Imaging
    • 2.16 Optical Coherence Tomography (OCT)
    • 2.17 Radioisotopes in Medicine
      • 2.17.1 Diagnostic Techniques in Nuclear Medicine
      • 2.17.2 Diagnostic Radiopharmaceuticals
      • 2.17.3 Supplies of Radioisotopes
      • 2.17.4 Contrast Media in Medical Imaging
      • 2.17.5 Pricing Trends in Contrast Media
      • 2.17.6 Economics of Contrast Agents
        • 2.17.6.1 Reimbursement and Contrast Media
        • 2.17.6.2 Negotiations on Pricing
      • 2.17.7 Pricing in CT Contrast Agents
      • 2.17.8 MRI Contrast Agents
        • 2.17.8.1 Pricing in MRI Contrast Agents
      • 2.17.9 Ultrasound Contrast Agents
  • 3. Market Analysis
    • 3.1 Medical Imaging and Information Technology Industry
    • 3.2 Medical Imaging: Revenue Scenario in 2009
    • 3.3 Popular Imaging Systems in 2009
    • 3.4 Spending in IT Infrastructure
      • 3.4.1 Clinical IT Spending
    • 3.5 Global Market for Medical Imaging
      • 3.5.1 Global Medical Imaging Market by Modality
    • 3.6 Global Market for General X-Rays
    • 3.7 Global Market for Ultrasound (US)
      • 3.7.1 Global Market for Portable Ultrasound
    • 3.8 Global Market for Magnetic Resonance Imaging (MRI)
    • 3.9 Global Market for Computed Tomography (CT)
    • 3.10 Global Market for Cardiovascular X-Ray
    • 3.11 Global Market for Nuclear Medicine
      • 3.11.1 Global Market for SPECT/PET
      • 3.11.2 Long-Term Opportunities in SPECT in the Context of Technetium Shortage
      • 3.11.3 High Energy Uranium (HEU) vs. Low Energy Uranium (LEU)
      • 3.11.4 Effect of the Technetium Shortage on the SPECT Market
      • 3.11.5 Improved Efficiency of New SPECT Cameras
      • 3.11.6 New Radiopharmaceuticals in Nuclear Procedures
      • 3.11.7 New Cardiology Products
    • 3.12 Global Market for PET/CT
    • 3.13 Global Oncology Biomarkers Market
    • 3.15 Global Medical Displays and Post-Processing Software Market
      • 3.15.1 Selected Medical Imaging Software
    • 3.16 Global Market for Connectors in the Medical Electronics Market
    • 3.17 North American Market for Medical Imaging
      • 3.17.1 North American Market for Magnetic Resonance Imaging (MRI)
      • 3.17.2 U.S. Market for Computed Tomography (CT)
      • 3.17.3 U.S. Market for Multi-Slice CT Scanners
      • 3.17.4 U.S. Market for SPECT and PET Radiopharmaceuticals
        • 3.17.5.1 Medicare Payment for SPECT/CT Procedures in the U.S.
      • 3.17.6 U.S. Market for Positron Emission Tomography (PET)
    • 3.18 Radiology Practice in the U.S.
    • 3.19 U.S. Market for Brachytherapy Products
      • 3.20.2 Advances in Mammography in the U.S.
      • 3.20.4 U.S. Market for Partial Breast Irradiation
      • 3.20.5 Trends in Breast Cancer Mortality in the U.S
      • 3.20.6 Medicare Reimbursement for Mammography Services in the U.S.
      • 3.20.7 U.S. Market for Irradiated Microspheres for Liver Cancer
      • 3.20.8 U.S. Market for Radiation Therapy
    • 3.23 U.S. Market for Healthcare IT
      • 3.23.1 EMR Adoption
      • 3.23.2 Legitimacy of PHRs
      • 3.23.3 Cost Containment
      • 3.23.4 Emergence of Alternate Care Delivery Models
      • 3.23.5 War on Medicare Fraud
      • 3.23.6 Focus on Outbreak Preparedness
      • 3.23.7 Intensification of Patient Safety Initiatives
      • 3.23.8 Short Supply of Healthcare Professionals
      • 3.23.9 Storage and Business Continuity Concerns
      • 3.23.10 Physician Groups Joining Healthcare Systems
      • 3.23.11 U.S. Market for Healthcare IT
      • 3.23.12 Software Applications and Market in Medical Imaging
    • 3.24 Medical Imaging in Canada
      • 3.24.1 Funding for Medical Imaging Services in Canada
      • 3.24.2 Medical Imaging Fees in Canada
      • 3.24.3 Medical Imaging Market in Canada
      • 3.24.4 Canadian Demand for Medical Imaging Products
      • 3.24.5 Medical Imaging in Northern Canada
      • 3.24.6 Nuclear Medicine in Canada
    • 3.25 Medical Imaging in Europe
      • 3.25.1 Growing Applications in Interventional Cardiology
      • 3.25.2 Sluggish Growth of Cardiac MRI
      • 3.25.3 Trend of Miniaturization and Echocardiography
      • 3.25.4 Future of Medical Imaging in Europe
      • 3.25.6 Picture Archiving and Communication Systems Market in Europe
      • 3.25.7 European Market for Digital Radiography (DR)
      • 3.25.8 European Market for Computed Radiography
      • 3.25.9 European Market for MRI
      • 3.25.10 Mammography in Europe
    • 3.26 Emerging Markets in Medical Imaging
      • 3.26.1 Medical Imaging in China and India
    • 3.27 Medical Imaging Market in China
      • 3.27.1 Market for Ultrasound in China
      • 3.27.2 Multinational Medical Imaging Companies in China
    • 3.28 Medical Imaging Market in India
      • 3.28.1 Equipment Providers in India
      • 3.28.2 Off-shoring of Radiology
      • 3.28.3 Medical Imaging Industry in India
      • 3.28.4 MRI Market in India
      • 3.28.5 Nuclear Medicine in India
      • 3.28.6 Indian Market for CT Systems
      • 3.28.7 X-Ray Market in India
      • 3.28.8 Digital Radiography in India
      • 3.28.9 Cath Labs in India
      • 3.28.10 Ultrasound Equipment Market in India
      • 3.28.11 Endoscopy Equipment Market in India
      • 3.28.12 Nuclear Medicine Equipment and Consumable Market in India
  • 4. Funding Arrangements for Medical Imaging Procedures
    • 4.1 The Working of the Systems
      • 4.1.1 Waiting Times for Medical Imaging Procedures in Canada
      • 4.1.2 Funding for Medical Imaging in France
      • 4.1.3 Funding for Medical Imaging in Germany
      • 4.1.4 Funding of Medical Imaging in New Zealand
      • 4.1.5 Funding for Medical Imaging in the U.K.
      • 4.1.6 Funding for Medical Imaging in the U.S.
      • 4.1.7 Funding of Medical Imaging in Japan
  • 5. Health and Medical Imaging Expenditures in OECD Countries
    • 5.1 Diagnostic Imaging Equipment and Utilization Statistics
      • 5.1.2 Gamma Cameras per Million of Population in OECD Countries
    • 5.2 Utilization of Medical Imaging Modalities in OECD Countries
  • 6. Company Profiles
    • 6.1 3mensio Medical Imaging BV
    • 6.2 Agfa HealthCare
    • 6.3 Analogic Corporation
      • 6.3.1 Computed Tomography Systems and Subsystems
      • 6.3.2 Magnetic Resonance Imaging Power Solutions
      • 6.3.3 Specialized Ultrasound Solutions
      • 6.3.4 Digital Radiography Subsystems
      • 6.3.5 Radiation Therapy Solutions
    • 6.4 Ardent Sound, Inc
    • 6.5 Avreo, Inc.
    • 6.6 Bard Access Systems, Inc.
    • 6.7 Biosound Esaote, Inc,
    • 6.8 BK Medical
    • 6.9 BRIT Systems, Inc.
    • 6.10 Canon U.S.A., Inc.
    • 6.11 Candelis
    • 6.12 Cedaron Medical, Inc.
      • 6.12.2 OrthoCare
    • 6.13 Chison Medical Imaging, Co., Ltd.
    • 6.14 DR Systems, Inc.
    • 6.15 Focus Surgery, Inc.
      • 6.15.1 Sonablate
    • 6.16 Fonar Corporation
      • 6.16.1 The Upright MRI
      • 6.16.2 Fonar 360
    • 6.17 Fujifilm Medical Systems USA, Inc.
    • 6.18 Fukuda Denshi Co., Ltd.
    • 6.19 GE Healthcare
    • 6.20 Hitachi Medical Corporation
    • 6.21 Hermes Medical Solutions
    • 6.22 Hologic, Inc.
      • 6.22.1 Hologic's Medical Imaging Product Offerings
        • 6.22.1.1 Selenia Dimentions 2D Full Field Digital Mammography System
        • 6.22.1.2 Screen-Film Mammography Systems
        • 6.22.1.3 R2 ImageChecker Digital CAD
        • 6.22.1.4 SecurView Diagnostic Workstations
        • 6.22.1.5 Discovery
    • 6.23 Imaging Diagnostic Systems, Inc.
      • 6.23.1 CTLM
      • 6.23.2 Invivo Corporation
      • 6.23.3 DynaSuite Neuro
      • 6.23.4 DynaCAD for Breast
      • 6.23.5 DynaCAD for Prostate
    • 6.24 InfiMed, Inc.
    • 6.25 InSite One, Inc.
    • 6.26 Intelerad Medical Systems
    • 6.27 Konica Minolta Medical Imaging USA, Inc.
      • 6.27.1 Regius Model 210
      • 6.27.2 Xpress CR
      • 6.27.3 Regius Nano CR
      • 6.27.4 ImagePilot
      • 6.27.5 IQue CR
      • 6.27.6 FlexDR C30
      • 6.27.7 Xpress DR Digital Radiography
    • 6.28 Lantheus Medical Imaging, Inc.
    • 6.29 Lumedx
    • 6.30 MEDIAN Technologies S.A.
      • 6.30.1 LMS-Lung
      • 6.30.2 LMS-Lung/Track
      • 6.30.3 LMS-Liver
    • 6.31 Medis Medical Imaging Systems BV
    • 6.32 Medison America, Inc.
    • 6.33 Medtronic, Inc.
      • 6.33.1 PoleStar
      • 6.33.2 StealthStation i7 Integrated Surgical Navigation System
      • 6.33.3 O-arm
      • 6.33.4 StealthViz
    • 6.34 NanoScan Imaging, LLC
      • 6.34.1 N1177
    • 6.35 NovaRad
    • 6.36 The Phantom Laboratory
      • 6.36.1 Catphan
      • 6.36.2 Magphan
      • 6.36.3 ADNI Magphan
      • 6.36.4 Specphan
      • 6.36.5 Rando
      • 6.36.6 RSVP Phantom Head
      • 6.36.7 RSVP Phantom Pelvis
      • 6.36.8 Phantom Patient
      • 6.36.9 Sectional Phantoms
      • 6.36.10 Liqui-Phil
    • 6.37 Philips Healthcare
    • 6.38 Sectra Medical Systems S.L.
    • 6.39 Schick Technologies, Inc.
    • 6.40 ScImage, Inc.
    • 6.41 Siemens Healthcare
    • 6.42 Shimadzu Corporation
    • 6.43 SonoSite, Inc.
    • 6.44 Spacelabs Healthcare, Inc.
      • 6.44.1 Sentinel
    • 6.45 Syntermed, Inc.
      • 6.45.1 Emory Cardiiac Toolbox
      • 6.45.2 Syntermed Live
      • 6.45.3 Nuclear Report Professional
      • 6.45.4 NeuroQ
      • 6.45.5 EQuAL
    • 6.46 TeraMedica, Inc.
    • 6.47 TeraRecon, Inc.
    • 6.48 TomTec Imaging Systems GmbH
    • 6.49 Toshiba America Medical Systems, Inc.
      • 6.49.1 Infinix-i systems
      • 6.49.4 Viamo
      • 6.49.5 Radrex-i
    • 6.50 UltraRAD Corporation
    • 6.51 Varian Medical Systems, Inc.
    • 6.52 Vepro
    • 6.53 Vidar Systems Corporation
    • 6.54 Vital Images, Inc
    • 6.55 VuCOMP, Inc.
    • 6.56 Xoran Technologies, Inc.
  • List of Appendix
    • Appendix 1: Medical Imaging Technologies
    • Appendix 1.1: Ultrasound Systems
    • Appendix 1.2: Computed Tomography
    • Appendix 1.3: Magnetic Resonance Imaging (MRI)
    • Appendix 1.4: Digital X-Ray
    • Appendix 1.5: Positron Emission Tomography (PET)
    • Appendix 2: Current and Future Trends in Medical Imaging Electronics
    • Appendix 2.1: Power Management
    • Appendix 2.2: Miniaturization and Integration
    • Appendix 3: Supply of Medical Radioisotopes
    • Appendix 3.1: Potential for New Reactors
    • Appendix 3.2: Processing Capacities and Restraints
    • Appendix 4: Opportunities in the Middle East for Healthcare and Medical Imaging Products
    • Appendix 4.1: The Largest U.S. Customers in the Middle East Region
    • Appendix 4.2: U.S. Exports of Medical Imaging Products to the Middle East
    • Appendix 5: Value of Radiation Therapy and Medical Imaging
    • Appendix 5.1: Effective Use of Medical Radiation
    • Appendix 5.2: Innovations to Reduce Radiation Dose
    • Appendix 5.3: Innovations in CT Imaging
    • Appendix 5.4: Effectiveness of Radiation Therapy
    • Appendix 5.5: Efforts to Minimize Radiation Dose
    • Appendix 5.6: New Dose Check Features
  • List of Figures
    • Figure 1.1: Major Drivers of Healthcare Costs in the U.S., 2010
    • Figure 1.2: Growth in Medicare Allowed Services and Charges for Medical Imaging in the U.S., 1995-2009
    • Figure 1.3: Hospital Imaging Volume Projections in the U.S., 2005-2015
    • Figure 3.1: Medical Imaging Markets by Region, 2009
    • Figure 3.2: Global Medical Imaging Market by Modality, 2009
    • Figure 3.3: Global Market for General X-Rays, 2009-2016
    • Figure 3.4: Global Market for Ultrasound, 2009-2016
    • Figure 3.5: Global Market for Portable Ultrasound Equipment, 2009-2014
    • Figure 3.6: Global Magnetic Resonance Imaging (MRI) Market by Geography, 2010
    • Figure 3.7: Global Market for MRI, 2009-2016
    • Figure 3.8: Global CT Market, 2004-2009
    • Figure 3.9: Global Market for Computed Tomography, 2009-2016
    • Figure 3.10: Global Market for Cardiovascular X-Ray, 2009-2016
    • Figure 3.11: Market for Nuclear Medicine, 2009-2016
    • Figure 3.12: Estimated Lifetime Risks for Alzheimer's by Age and Sex in the U.S.
    • Figure 3.13: Global Market for SPECT/PET, 2010-2015
    • Figure 3.14: Global Market for PET/CT, 2010-2015
    • Figure 3.15: Global Market for Biomarkers, 2009-2014
    • Figure 3.16: Biomarker Patent Filings by Type of Cancer, 2010
    • Figure 3.17: Global Market for Breast Cancer, 2009-2016
    • Figure 3.18: Global Market for Medical Displays and Post-Processing Software, 2009-2014
    • Figure 3.19: Global Market for Connectors in the Medical Electronics, 2009-2014
    • Figure 3.20: North American Market for Medical Imaging Equipment, 2009-2016
    • Figure 3.21: North American Market for Magnetic Resonance Imaging, 2010-2015
    • Figure 3.22: U.S. Market for Computed Tomography (CT), 2008-2015
    • Figure 3.23: Market for Multi Slice CT Systems in the U.S., 2008-2015
    • Figure 3.24: U.S. Market for Radiopharmaceuticals, 2009-2017
    • Figure 3.25: U.S. Market for SPECT, 2009-2017
    • Figure 3.26: U.S. Market for PET, 2009-2017
    • Figure 3.27: U.S. Market for Brachytherapy Products, 2008-2016
    • Figure 3.28: New Breast Cancer Incidence in North America, 2009-2017
    • Figure 3.29: U.S. Market for Mammography, 2008-2013
    • Figure 3.30: U.S. Market for Partial Breast Irradiation, 2008-2016
    • Figure 3.31: Age-Specific Death Rates Due to Breast Cancer by Age Group, U.S., 1996 and 2006
    • Figure 3.32: U.S. Market for Irradiated Microspheres for Liver Cancer, 2008-2016
    • Figure 3.33: Age-Specific Incidence Rate of Breast Cancer in U.K., 2007
    • Figure 3.34: U.S. Market for PACS, 2008-2015
    • Figure 3.35: Number of U.S. Hospitals with PACS Installed, 2000-2008
    • Figure 3.36: Number of U.S. Hospitals with Installed PACS, 2000-2008
    • Figure 3.37: Replacements and New PACS Purchases, 2000-2008
    • Figure 3.38: PACS Installation by Bed Size in the U.S., 2000-2008
    • Figure 3.39: PACS Modalities Installations in the U.S. Hospitals, 2005 and 2008
    • Figure 3.40: PACS Company Market Share, 2008
    • Figure 3.41: PACS Image Distribution in Hospital Departments, 2006-2008
    • Figure 3.42: PACS Images Accessibility by Physician, 2006-2008
    • Figure 3.43: RIS and PACS Interface, 2005-2008
    • Figure 3.44: U.S. Market for Healthcare IT, 2009-2014
    • Figure 3.45: U.S. Market for Software Applications, 2009-2014
    • Figure 3.46: Canadian Market for Medical Imaging Modalities, 2009-2014
    • Figure 3.47: Percent Distribution of Diagnostic Imaging Examinations in Canadian Hospitals, 2006
    • Figure 3.48: Medical Imaging Market Leaders and their Market Share in Canada, 2009
    • Figure 3.49: Types and Breakdown of Nuclear Medicine Procedures that Can be DoneUsing Tc-99m
    • Figure 3.50: Global Nuclear Medicine Market Share by Reactor, 2008
    • Figure 3.51: Percent Global Market for Tc-99m by Geography/Country and Doses
    • Figure 3.52: Western European Market for Medical Imaging Equipment, 2009-2016
    • Figure 3.53: Imaging Diagnostics Market in Central Europe, 2009-2012
    • Figure 3.54: European Market for PACS, 2009-2016
    • Figure 3.55: European Market for Digital Radiography, 2009-2016
    • Figure 3.56: European Market for Computed Radiography, 2009-2016
    • Figure 3.57: European Market for Magnetic Resonance Imaging (MRI), 2010-2015
    • Figure 3.58: Percentage of Causes of Death in Women
    • Figure 3.59: Diagnostic Imaging Market in Emerging Markets, 2009-2016
    • Figure 3.60: Diagnostic Imaging Equipment Installations in the Two Emerging Economies, 2009
    • Figure 3.61: Middle-class population as a % of the total population in India, 1998-2010
    • Figure 3.62: Market for Medical Imaging Equipment in Greater China, 2009-2016
    • Figure 3.63: Market for Ultrasound in China, 2009-2014
    • Figure 3.64: Market for Medical Imaging Equipment in India, 2009-2016
    • Figure 3.65: Number of MRI Units in India, 2009
    • Figure 3.66: Indian CT Systems Market by Value, 2009
    • Figure 3.67: Indian CT Systems Market by Unit, 2009
    • Figure 3.68: Market for X-Ray in India, 2006-2009
    • Figure 3.69: Indian X-Ray Equipment Market by Unit (%), 2009
    • Figure 3.70: Indian Market for Cath Labs by Value, 2008-2009
    • Figure 3.71: Indian Cath Lab Market by Units, 2008-2009
    • Figure 3.72: Indian Ultrasonic Equipment Market Share by Segment, 2007
    • Figure 3.73: Percent Indian Market Share in Endoscopy by Segment, 2009
    • Figure 3.74: Indian Market for PET Systems and Gamma Camera, 2009
    • Figure 5.1: Public and Private Expenditure on Health % of GDP in Select OECD Countries
    • Figure 5.2: Angiography Units per Million of Population in OECD Countries
    • Figure 5.3: CT Scanners per Million of Population in OED Countries
    • Figure 5.4: Gamma Cameras per Million of Population in OECD Countries
    • Figure 5.5: Mammography Units per Million of Population in OECD Countries
    • Figure 5.6: MRI Scanners per Million of Population in OECD Countries
    • Figure 5.7: PET Scanners per Million of Population in OECD Countries
    • Figure 5.8: CT Exams per Scanner in OECD Countries
    • Figure 5.9: CT Exams per 1,000 of Population in OECD Countries
    • Figure 5.10: MRI exams per Scanner in the OECD countries
    • Figure 5.11: MRI Exams per 1,000 of Population in OECD Countries
    • Figure App. 1.1: Block Diagram of Imaging Ultrasound Equipment
    • Figure App. 1.2: Block Diagram of a Medical CT System
    • Figure App. 1.3: Block Diagram of a Medical MRI
    • Figure App 1.4: Block Diagram of Digital X-Ray
    • Figure App. 1.5: Block Diagram for Positron Emission Tomography
    • Figure App 2.1: Block Diagram of Portable Ultrasound System
    • Figure App. 3.1: Current Supply and Demand for Medical Radioisotopes, 2010-2024
    • Figure App. 3.2: Percent Market Share of Medical Radioisotopes by Reactor, 2010
    • Figure App. 4.1: U.S. Exports of Medical Products to the Middle East, 1996-2009
    • Figure App. 4.2: U.S. Exports of Medical Products to Israel, Saudi Arabia and Turkey, 1996-2009
    • Figure App. 4.3: U.S. Exports of Medical Imaging Products to Israel, Saudi Arabia and Turkey, 1996-2009
  • List of Tables
    • Table 1.1: Code-Specific Impacts of CMS Medicare Physician Fee Schedule
    • Table 1.2: CT Technical Revenue: Breakeven at Various Levels of Utilization in the U.S.
    • Table 1.3: MRI Technical Revenue: Breakeven at Various Levels of Utilization in the U.S.
    • Table 1.4: Reimbursement Reductions and Effect on Contribution Margin in U.S. Outpatient Imaging
    • Table 2.1: Properties of Scintillation Crystals in PET Imaging Systems
    • Table 2.2: Radioisotopes Used in Medical Imaging
    • Table 2.3: Comparative Data on X-Ray Contrast Media
    • Table 2.4: Properties of Low and Iso-Osmolar Contrast Agents
    • Table 2.5: A Sample of Common Radiological Contrasting Agents and Discount Rates
    • Table 2.6: Common MRI Contrast Agents and Discount Rates
    • Table 2.7: Common Ultrasound Contrast Agents and Discount
    • Table 3.1: Top Ten Imaging Systems Purchased, 2006-2009
    • Table 3.2: IT Spending in the U.S. Hospitals, 2010-2015
    • Table 3.3: Biomarkers Used in Cancer Diagnosis
    • Table 3.4: Medicare Payment Rated for SPECT/CT Procedures in the U.S., 2010
    • Table 3.5: Medicare Reimbursement for PET Services in the U.S., 2010
    • Table 3.6: Female Breast Cancer Risk Factors
    • Table 3.7: FDA Approved Mammography Systems, Breast Tests and Breast Implants, 2000-2010
    • Table 3.8: Medicare Reimbursement for Mammography Procedures, 2009
    • Table 3.9: Mortality Rate in European Countries, 1989-2006
    • Table 3.10: Number of New Cases and Rates of Breast Cancer in the U.K., 2007
    • Table 3.11: Sources of Operating Funds for Medical Imaging Equipment in Canada, 2007
    • Table 3.12: Canadian Fee Structure for Medical Imaging Procedures
    • Table 3.13: Imaging Modalities Available in Whitehorse General Hospital
    • Table 3.14: Imaging Equipment in Watson Lake Hospital and the Health Centers
    • Table 3.15: Imaging Equipment in Stanton Territorial Hospital
    • Table 3.16: Diagnostic Imaging Equipment in Northern Territory Hospitals
    • Table 3.17: Imaging Technologies in the Qikiqtani General Hospital
    • Table 3.18: Diagnostic Imaging Equipment Installations in China and India, 2000-2009
    • Table 3.19: Availability of Medical Imaging Equipment per Million Populations in China and India, 2009
    • Table 3.20: Diagnostic Imaging Affordability in Emerging Economies
    • Table 3.21: Multinational Firms in China for Medical Imaging Products
    • Table 3.22: Installed Base of CT and MRI in India, China, Japan and Korea, 2010
    • Table 3.23: Medical Cyclotrons in India
    • Table 3.24: PET/CT Scanner Profile in India
    • Table 3.25: PET/CT Scanners: No. of Slices Used in India
    • Table 3.26: Imaging Protocols in PET/CT in India
    • Table 3.27: Drivers of X-Ray Industry in India
    • Table 3.28: Major Ultrasound Market Vendors in India
    • Table 3.29: Ultrasound Equipment Vendors in India
    • Table 4.1: Weeks Waited for Medical Imaging Procedures in Canada
    • Table 4.2: Reimbursement Rates for Medical Imaging Procedures in Germany
    • Table 4.3: Reimbursement Rates for Medical Imaging Procedures in New Zealand
    • Table 4.4: Non-Mandatory Tariffs for Medical imaging in the U.K, 2009-2010
    • Table 4.5: Number and Cost of Medical Imaging Services in the U.K., 2008-09
    • Table 4.6: Percent Distribution of Health Services Visit by Expected Source of Payment, U.S.
    • Table 4.7: Cost of MRI and PET in Different States and Cities in the U.S.
    • Table 6.1: 3mensio's Product Portfolio
    • Table 6.2: Agfa's Medical Imaging Products
    • Table 6.3: Ardent's Product Portfolio
    • Table 6.4: Avreo's Radiology Workflow Solutions
    • Table 6.5: Bard's Imaging Products
    • Table 6.6: Biosound Esaote's Ultrasound Systems
    • Table 6.7: BK Medical's Product Portfolio
    • Table 6.8: BRIT System's Healthcare IT Solutions
    • Table 6.9: Canon's Medical Imaging Products
    • Table 6.10: Candelis' Software Solutions for Medical Imaging
    • Table 6.11: Chison's Ultrasound Product Portfolio
    • Table 6.12: DR System's Healthcare IT Solutions
    • Table 6.13: Fujifilm Medical Systems' Product Portfolio
    • Table 6.14: Fakuda's Ultrasound Products
    • Table 6.15: GE Healthcare's Medical Imaging Modalities and Contrast Media
    • Table 6.16: Hitachi's Medical Imaging Product Portfolio
    • Table 6.17: Hermes' Medical Imaging Software Solutions
    • Table 6.18: InfiMed's Product Portfolio
    • Table 6.19: InSite One's Software Solutions
    • Table 6.20: Intelerad's Software Solutions
    • Table 6.21: Lantheus' Contrast Agent Products
    • Table 6.22: Lumedx's Cardiovascular Information System Solutions
    • Table 6.23: Medis' Software for Various Medical Imaging Modalities
    • Table 6.24: Medison's Medical Imaging Products
    • Table 6.25: NovaRad's Product Portfolio
    • Table 6.26: Philips' Computed Tomography Systems
    • Table 6.27: Philips' Nuclear Medicine Products
    • Table 6.28: Philips' Radiography Systems
    • Table 6.29: Philips' Radiography/Fluoroscopy (R/F) Products
    • Table 6.30: Philips' Magnetic Resonance Imaging (MRI) Systems
    • Table 6.31: Philips' Mammography Systems
    • Table 6.32: Spectra's Product Portfolio
    • Table 6.33: Schick's Product Portfolio in Medical Imaging
    • Table 6.34: Sclmage's Product Portfolio
    • Table 6.35: Siemens' Product Portfolio
    • Table 6.36: Shimadzu's Product Portfolio
    • Table 6.37: TeraMedica's Portfolio of Solutions and Products
    • Table 6.38: TeraRecon's Portfolio of Imaging Solutions
    • Table 6.39: TomTec's Product Portfolio
    • Table 6.40: UltraRAD's Product Portfolio
    • Table 6.41: Vepro's Product Portfolio
    • Table 6.42: Vidar's Product Portfolio
    • Table 6.43: Vital Images' Product Portfolio
    • Table App. 3.1: Major Current 99Mo Producing Reactors, 2010
    • Table App. 3.2: Potential Reactor-Based Projects for 99Mo Production, 2010-2024
    • Table App. 3.3: Processing Capacity of Major Reactors, 2010
    • Table App. 3.4: Demand Scenarios for 99Mo, 2010-2025